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Abstract—We investigated the effect of two commonly
studied surfactants, sodium dodecyl sulfate (SDS) and
dodecyl trimethylammonium bromide (C12TAB), on skin
barrier properties. Using skin conductivity, FT-IR of stratum
corneum samples, and penetration of radiolabelled SDS, we
determined that addition of C12TAB lowers the ability of
SDS to perturb skin’s barrier properties. Ultraﬁltration
experiments revealed that addition of C12TAB serves to
decrease the concentration of monomers and sub-micellar
aggregates. None of the measured skin properties including
enhancement of skin conductivity, perturbation of lipid
structure and skin concentration of SDS correlated with the
total SDS concentration in the donor compartment (i.e., the
total SDS concentration). However, all these parameters
correlated well against the concentration of monomers and
sub-micellar aggregates. These ﬁndings provide the evidence
of the importance of monomer and sub-micellar components
in altering skin barrier properties.
Keywords—Transdermal, Surfactant, Mixture, Synergy,
Mechanism.
INTRODUCTION
Delivery of actives into and across the skin plays an
important role in several topical, transdermal, dermato-
logical, and personal care applications.
43 While small,
lipophilic molecules permeate the skin relatively easily,
permeation of larger and hydrophilic molecules is hin-
dered by the low permeability of stratum corneum (SC),
the outermost layer of skin. This is particularly chal-
lenging since a signiﬁcant fraction of currently marketed
therapeutic drugs are hydrophilic in nature.
16 Transder-
mal drug delivery is also appealing for the delivery
of macromolecules such as insulin and vaccines, which
otherwise have to be injected using needles and
syringes.
29,43 Needle-based methods are severely limited
bypainandneedle-phobiaandleadtoseverepatientnon-
compliance.
24 In addition to avoiding needles, transder-
mal deliveryofferssustained release ofdrugsandcontrol
over termination. Delivery of macromolecules across the
skin, however, isseverely limited by the low permeability
of skin. To date, there are about 20 drugs that are deliv-
ered using FDA-approved transdermal delivery meth-
ods, not including drugs delivered as creams or
ointments.
38 This means that there is vast room for
improvement in delivery through transdermal routes,
which has resulted in the development of novel method-
ologies to transiently enhance skin permeability using
physical or chemical means.
2,23,33,39,47 Some physical
means of penetration enhancement include the use of
jet-injectors,
17,44 sonophoresis (ultrasound),
3,30 ionto-
phoresis,
7,20 electroporation,
8 and microneedles.
13,37
Penetration enhancement can also be achieved by using
chemicals,
23,39,45 such as surfactants, fatty acids, esters,
and amines to penetrate into the skin and disrupt the
structure and packing of lipids and proteins within the
SC. Chemical penetration enhancers (CPEs) are capable
of enhancing skin permeability to molecules; however,
this enhancement is often accompanied by irritation,
21,42
thereby limiting their applications. Use of CPE mixtures
hasbeenproposedasa potentialsolution todecouplethe
enhancing and irritating effects of CPEs.
10,23
Mixtures of CPEs, in particular surfactants, have
already been shown to yield potent formulations with-
out necessarily elevating the irritation.
23 Surfactants
possess the ability to self-assemble to form micellar
structures and therefore can exhibit more complex
interactions with skin compared to single CPEs. This
property allows for the manipulation of surfactant
mixtures to control their interactions with the
skin.
10,11,31,46Here,wereportontheeffectofmixingtwo
extensively studied surfactants, sodium dodecyl sulfate
(SDS) and dodecyl trimethylammonium bromide
(C12TAB),
19,34,35ontheperturbationoftheskinbarrier.
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1215We particularly focus on assessing how the presence of
C12TAB inﬂuences the effect of SDS on skin barrier.
EXPERIMENTAL SECTION
Materials
Ultrapure SDS and C12TAB were purchased from
Sigma-Aldrich(StLouis,MO)andusedwithoutfurther
puriﬁcation. All solutions were prepared in phosphate
buffered saline (PBS) with the exception of samples that
were prepared for ultraﬁltration studies. Those samples
were prepared in Millipure water and not PBS because
the salts in PBS interfere with dye complexation.
14C-
radiolabelled SDS was purchased from Sigma-Aldrich
(StLouis,MO).Mixedmicellarsolutionswereprepared
with SDS alone or with SDS + C12TAB at various
concentrations and SDS:C12TAB molar ratios.
Skin Preparation
Porcine skin was utilized as the skin model in all
experiments. Skin was obtained from Lampire Bio-
logicals (Pipersville, PA) and stored at 280  C for use
as needed. Storage at 280  C has minimal eﬀect on the
barrier properties of skin.
23 Skin was removed from
the freezer prior to the experiment and was allowed to
thaw at room temperature. Skin was never exposed to
repeated freeze and thaw cycle.
Skin Electrical Impedance (Conductivity)
Skinbarrierpropertiescanbeanalyzedbydetermining
the ability of ions to ﬂow across the skin (i.e., measuring
the skin’s conductivity).
22 The ability of the surfactant
solutions to reduce skin barrier properties was measured
by quantifying their effect on skin electrical impedance.
Skin conductivity is a good indicator of skin perme-
ation.
22 It has been shown by Karande et al.
22 that sig-
niﬁcant agreement exists between the skin electrical
resistanceanalysisandstandardpermeationexperiments
usingaFranzdiffusioncell(FDC).Fullthicknessporcine
skin was cut into 1 cm
2 pieces and secured in a FDC
(PermegearInc., Riegelsville, PA) with a 0.2 cm
2 contact
area and the SC side facing the donor compartment.The
conductivityofeachskinsamplewasinitiallymeasuredin
thepresenceofPBStodeterminetheintegrityoftheskin.
Skin’s electrical conductivity was measured using proce-
dures described by Karande et al.
22
Ultraﬁltration
Ultraﬁltration experiments were carried out fol-
lowing the experimental procedure used by James-
Smith et al.
18 Ten thousand molecular weight cutoff
(MWCO) Centricon YM-10 ultracentrifugation ﬁlter
tubes were purchased from Fisher Scientiﬁc. Two
milliliters of SDS:C12TAB mixed micellar solutions of
various SDS:C12TAB ratios (from 100:0 to 90:10) with
various SDS concentrations were placed into the top
portion of the ultracentrifugation tubes and subse-
quently centrifuged at ~2,900g for approximately
10 min so that less than 10% (i.e., <200 lL) volume
was collected as ﬁltrate. Centrifugation was performed
under these conditions so as to minimize the effect on
micellar structure. All samples were centrifuged in an
Allegra X-12R Centrifuge (Beckman Coulter, Fuller-
ton, CA). The ﬁltrate was collected in the bottom
attachment and diluted for analysis by a slightly
modiﬁed dye complexation method.
40
Dye Complexation Method
Methylene blue reagent was purchased from Fisher
Scientiﬁc. Two milliliters of methylene blue reagent was
added to 2 mL of the diluted ﬁltrate from the ultraﬁl-
tration experiments. Two milliliters of chloroform was
addedandthesolutionwasshakenonaVortexmixerfor
approximately 30 s. Any SDS that was present in the
ﬁltratecomplexedwiththepositivelychargedmethylene
blue through electrostatic interactions, thus forming an
oil-solublecomplexthatpartitionedintothechloroform
organic phase. The solution was allowed to phase sep-
arate and the organic phase was removed and placed
into a separate test tube. This extraction process was
repeated two more times (i.e., 2 mL of chloroform was
added, shaken, and removed two more times for a total
chloroform volume of 6 mL) and the organic phase was
then analyzed by UV–Visible spectrometry at 652 nm.
SDS concentration was determined using a calibration
curve. Known concentrations of SDS from 5 to 30 lM
were mixed with methylene blue reagent and extracted
with chloroform to obtain the calibration curve. UV–
Vis analysis was done in a Shimadzu UV-1601 UV–vis
spectrometer (Shimadzu Scientiﬁc Instruments,
Columbia, MD). It has been shown C12TAB molecules
in C12TAB–SDS mixture in the concentration range
studied here are incorporated in the micelles
19 and
shouldnotinterferewithbindingoffreeSDSthatpasses
into the ﬁltrate with methylene blue.
Heat Stripping of Skin
Intact sheets of SC were obtained by heat stripping
porcine skin to separate the epidermis from the der-
mis.
25 The skin was ﬁrst removed from the 280  C
freezer and allowed to thaw to room temperature. The
skin was then placed in a 60  C PBS solution for
2 min. The skin was taken out of the PBS and the
epidermis was removed by scraping it away from the
JAMES-SMITH et al. 1216dermis with ﬂat-edged tweezers. The isolated epidermis
was then ﬂoated over 0.25% (w/v) trypsin (Sigma-
Aldrich, St Louis, MO) solution overnight at room
temperature (25  C) to digest the epidermal matrix.
26
The SC sample was removed from the trypsin after
24 h and washed with PBS until all traces of epidermal
debris was removed. It was allowed to dry for 24 h and
then cut into 1 sq. cm pieces.
FT-IR
Fourier Transform-Infrared Spectroscopy (FT-IR)
of the dry SC samples was carried out on a Nicolet
Magna 850 spectrometer (Thermo Electron Corp.,
Waltham, MA) setup at a resolution of 2 cm
21. FT-IR
has often been used to determine the effect of pene-
tration enhancers on the structural properties of the
SC.
1,23,27 The spectra were averaged over 100 scans
and subsequently smoothed, baseline corrected, and
saved in the comma separated value (csv) format for
further analysis by ORIGIN software (OriginLabs,
Northhampton, MA). The average initial peak area at
2850 for all samples was approximately 20.5 ± 4.0
(AU). After the initial spectra were taken, the SC
samples were placed into vials containing 1.5 mL of
surfactant solutions of various compositions and con-
centrations. The samples were allowed to soak for 24 h
and then washed by soaking and gentle swirling in
10 mL of fresh PBS three times. After the third wash,
the samples were dried and then ﬁnal FT-IR spectra
were taken and analyzed. Each formulation was stud-
ied in quadruplicate to determine its effect on the SC.
The structure of the lipids within the SC has been
correlated with skin’s barrier properties.
12 There are
two main ways in which surfactants tend to interact
with the lipids of the SC. They can partition into the
lipid bilayer, thereby disrupting the packing and
leading to the ﬂuidization of the bilayer. They could
also lead to the removal (extraction) of lipids from the
SC. Therefore, the effect of the formulations on the
lipid bilayers in the SC was determined by analyzing
changes in the lipid content in the SC. The integrated
peak area of the methylene symmetric stretching mode,
CH2sym, at 2850 cm
21 was used to quantify the effect
of formulations on SC. If the peak area at 2850 cm
21
increased after exposure to the surfactant formula-
tions, then it was concluded that surfactant molecules
had partitioned into the SC. In the case where the peak
area decreased, it was determined that the lipid mole-
cules had been extracted from the SC.
23
SDS Partitioning into Skin
14C-radiolabelled SDS was used to quantify the
amount of SDS that partitions into porcine skin
following a slightly modiﬁed version of the procedure
utilized by Moore et al.
31 Full thickness porcine skin
was cut into 1 cm
2 pieces, weighed, and secured in a
FDC with the SC side facing the donor compartment.
The skin was allowed to hydrate with PBS for 1 h and
then the PBS was removed from the donor well and
replaced with 200 lL of surfactant solution. The sur-
factant solutions were composed of mixtures of SDS
and C12TAB at different ratios and each solution
contained approximately 0.5 lCi/mL of
14C-SDS. The
surfactant solutions were allowed to remain in contact
with the skin for 2.5 h at room temperature. This
exposure time was chosen because the FDCs that were
used were smaller than the ones that were utilized by
Moore et al.
31 The skin was then blotted with a paper
towel to remove excess liquid, allowed to dry in a fume
hood for about 4 days and subsequently weighed. The
skin was solubilized by submerging it in 5 mL of
Solvable solution (PerkinElmer Life and Analytical
Sciences, Inc, Boston, MA) and heating overnight in
an oven at 60  C. After the skin was completely dis-
solved, a 2 mL aliquot of the solubilized solution was
diluted with 10 mL of Ultima Gold scintillation
cocktail (PerkinElmer Life and Analytical Sciences,
Inc, Boston, MA). The concentration of radiolabelled
SDS in the skin was measured in a scintillation counter
(Packard Tri-Carb 2100 TR). The concentration of
SDS in the skin ([SDS]skin) was subsequently calculated
using the measured radioactivity in skin and total SDS
concentration in the donor compartment in the fol-
lowing equation:
½SDS skin ¼
½
14C-SDS skin  ½ SDS 
½
14C - SDS donor   m
where [
14C-SDS]skin is the measured radioactivity in
skin, [SDS] is the total SDS concentration in the donor
compartment, [
14C-SDS]donor is the concentration of
radiolabelled SDS in the donor compartment, and m is
the dry weight of the skin.
RESULTS
Application of SDS:C12TAB mixtures to skin
led to a concentration- and composition-dependent
enhancement of transepidermal current (Fig. 1a). The
enhancement increased with increasing surfactant
concentration regardless of the speciﬁc composition of
SLS:C12TAB. This is expected since increasing con-
centration avails more surfactant for skin penetration.
The dependence on composition, however, was pecu-
liar. Speciﬁcally, addition of small amounts of C12TAB
led to a signiﬁcant decrease in transepidermal current
(Fig. 1a). Note that SDS constituted the majority of
Surfactant Mixtures in Penetration Enhancement 1217surfactant at all compositions and hence was expected
to be the primary determinant of barrier perturbation.
The enhancement in transepidermal current, however,
did not correlate with the portion of the total surfac-
tant concentration represented by SDS (i.e., the SDS
concentration in the donor) (Fig. 1b). Within each
speciﬁc composition of SLS:C12TAB, perturbation in
barrier properties correlated well with the total con-
centration, as is reported in the previous literature.
48
However, the correlation did not hold true over the
entire composition range. This suggests that donor
SDS concentration, on its own, cannot explain per-
turbation in barrier properties.
FT-IR analysis of SC samples conﬁrmed that the
dependence of transepidermal current on SDS:C12TAB
mirrored that of SC lipids (Fig. 2a). In particular,
higher concentrations of surfactants led to higher
increase in the area at 2850 cm
21. In addition, in most
cases, the change in area decreased with the addition of
C12TAB to SDS. For the 35 mM micelles, the change
in area actually increased when the C12TAB molar
ratio was increased from 5 to 10% (i.e., from 95:5 to
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FIGURE 1. (a) Enhancement in transepidermal current for mixed micellar solutions of SDS:C12TAB at different molar ratios and
total surfactant concentrations: 35 mM (black bars), 50 mM (upward striped bars), 70 mM (empty bars) or 100 mM (downward
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JAMES-SMITH et al. 121890:10). This could possibly be explained by the fact
that these values fall within the noise range of the
instrument (i.e., ±10% for 100 scans). This could also
explain the negative change in peak area for 35 mM at
95:5 SDS:C12TAB. The point to note is that addition
of C12TAB leads to signiﬁcant decrease in change in
peak area. Also, for 70 mM, there appears to be a
slight increase in change in peak area when the
C12TAB molar ratio was increased from 2 to 5% (i.e.,
98:2 to 95:5). This change is not statistically signiﬁcant;
as such, emphasis must be placed on the overall change
in peak area as the C12TAB molar ratio is increased
from 0 to 10%, which is a statistically signiﬁcant
change (p = 0.002). Note that the FT-IR analysis was
not performed for solutions at 100 mM because the SC
was very fragile at this concentration of SDS. Change
in area for all compositions and concentrations cor-
related with the enhancement in transepidermal cur-
rent (Fig. 2b, r
2 = 0.88).
Since the SDS concentration outside the skin, that is,
the total SDS concentration in the donor compart-
ment, did not correlate with transepidermal current
enhancement, we sought to determine whether the
concentration of SDS inside the skin correlates with
barrier perturbation. SDS concentration in the skin
was determined using
14C-radiolabelled SDS. SDS
penetration in the skin varied with the composition
and concentration of SDS in the donor compartment
(Fig. 3a). Further, this dependence was qualitatively
similar to that of transepidermal current on the same
parameters. Regardless of the concentration and
composition, transepidermal current correlated well
with SDS concentration inside the skin (Fig. 3b).
Data in Figs. 1, 2, and 3 suggest that surfactant-
induced skin effects correlate with the SDS concen-
tration inside the skin but not in the donor compart-
ment. A question then arises why does not the
concentration of SDS inside the skin correlate with
that in the donor compartment. One possibility is that
the total SDS concentration in the donor compartment
is not an accurate measure of SDS ‘‘available’’ for skin
penetration. For example, if only SDS monomers and
sub-micellar aggregates, but not micelles, are able to
penetrate the skin, then the available SDS for pene-
tration will vary greatly as a function of concentration
and composition. In this regard, C12TAB may have a
particularly signiﬁcant role to play. Addition of
C12TAB to SDS is known to increase the stability of
micelles and sub-micellar aggregates, thereby reducing
the concentration of monomeric SDS.
18,35 To assess
this possibility, concentration of monomers and sub-
micellar aggregates in SDS:C12TAB mixtures was
determined using ultraﬁltration.
18 A 10,000 MWCO
ﬁlter was used since a typical SDS micelle has an
approximate molecular weight of 18,720. Concentra-
tion of monomeric and sub-micellar SDS exhibited a
strong dependence on concentration and composition
(Fig. 4). It increased somewhat with increasing con-
centration for all compositions, although the increase
was most prominent at 100 mM concentration.
Regardless of the total surfactant concentration, the
concentration of monomeric and sub-micellar SDS
decreased with increasing fraction of C12TAB. This
observation is in agreement with previous reports
indicating that addition of C12TAB leads to stabiliza-
tion of SDS micelles.
18,35,36
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Surfactant Mixtures in Penetration Enhancement 1219SDS concentration in the ﬁltrate (i.e., monomer/
sub-micellar SDS concentration) correlated well with
SDS concentration inside the skin across all composi-
tions tested in this study (Fig. 5a, r
2 = 0.8). For
comparison, a plot of SDS concentration inside skin
against donor SDS concentration is also shown
(Fig. 5b, r
2 = 0.5). Comparison of Figs. 5aa n d5b
reveal that concentration of monomeric and sub-
micellar SDS is a better determinant of SDS con-
centration inside the skin and hence, skin barrier
perturbation, compared to SDS concentration in the
donor.
DISCUSSION
Transient disruption of SC allows for increase in
skin permeability, thereby facilitating transdermal and
topical drug delivery. While surfactants have been
extensively studied as penetration enhancers, the
eﬀects of mixed surfactant systems on skin perme-
ability have yet to be investigated in depth. Here, we
have analyzed how mixing two commonly studied
surfactants, SDS and C12TAB at various ratios affects
the extent of enhancement. SDS and C12TAB were
used as model surfactants since the thermodynamics of
this system are relatively well studied.
Addition of C12TAB to SDS is known to induce
signiﬁcant changes in the micellar structure and sta-
bility. Patist et al.
35 have previously shown that SDS
micellar stability may be tailored by the addition of
oppositely charged surfactants such as alkyltrimethyl-
ammonium bromides (CnTABs). The long-chain TABs
enhance SDS micellar stability, as measured by relax-
ation time, by up to 2000 times.
36 Increased micellar
stability, in turn, has been shown to reduce the
monomer concentration.
18 In the concentration range
and the molar ratios studied here, there was little-to-no
change in micelle size with the addition of C12TAB.
The highest molar ratio of C12TAB was capped at 10%
to limit the effects of viscosity and micelle size. The
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JAMES-SMITH et al. 1220micelle sizes, as determined by dynamic light scatter-
ing, were in the range of 7–12 nm for all micelles
studied.
In this study, the distribution of surfactants among
micelles and monomers/sub-micellar population was
determined using ultraﬁltration.
28 In this technique, a
small portion (<10%) of the surfactant solution is
passed through ultracentrifuge tubes containing a
nanoporous membrane with a nominal MWCO that is
smaller than that of the micelles.
28 This methodology
has been previously used to determine the presence of
sub-micellar aggregates in surfactant solution (aggre-
gates of surfactant containing less monomers than the
aggregation number of the micelle; e.g., dimers, tri-
mers, and other multimers).
18 Of particular interest is
the fact that this technique has been utilized to dem-
onstrate that addition of C12TAB to SDS leads to
stabilization of micelles and sub-micellar aggregates
and such stabilization decreases and even virtually
eliminates sub-micellar aggregates.
18
Data in Fig. 4 show that addition of C12TAB indeed
led to reduction of sub-micellar population of SDS.
Further, the concentration of sub-micellar SDS corre-
lated well with skin SDS concentration, transepidermal
current and change in peak area at 2850 cm
21. None of
these measured skin parameters correlated with SDS
concentration in the donor. These observations lead to
a key question: is surfactant-mediated barrier disrup-
tion induced by the penetration of micelles or monomer
surfactants? In spite of its high relevance to drug
delivery and personal care, this question has been rel-
atively unexplored in the literature. Among a limited
number of studies that directly address this questions,
Moore et al.
31 have reported that transepidermal cur-
rent in presence of SDS increases even for concentra-
tions above the critical micelle concentration, based on
which, they concluded that SDS micelles are able to
penetrate into the skin. Addition of a nonionic surfac-
tant, dodecyl hexa(ethylene oxide), to SDS led to
decreased partitioning of SDS into skin,
32 which was
attributed to the larger hydrodynamic radius of the
micelles which would prohibit the penetration of the
micelles into the skin. Rhein et al.
41,42 have also
investigated the addition of a milder co-surfactants
(C12–C14 alkyl 6 and 7-ethoxy sulfate) to SDS to
decrease irritation associated with the pure SDS sys-
tem. They hypothesized that the decrease in irritation
was due to the lowering of the cmc, which consequently
results in a lowering of the monomer concentration of
SDS.
42 In other studies, a number of publications have
reported on the possibility of penetration of intact lipid
vesicles into the skin.
4–6,9 It has also been shown that
the addition of hydrophobically modiﬁed polymers to
surfactant-based cleansers can serve to reduce their
irritation potential.
10
Our ﬁndings suggest that penetration of sub-micellar
aggregates into skin represents an alternate hypothesis
to the penetration of intact micelles into skin in terms of
explaining the eﬀect of surfactants on skin’s barrier
properties. This ﬁnding would suggest that when
forming systems for skin penetration, one must take
into account micelle stability, which has been shown to
relate directly to the concentration of sub-micellar
aggregates (i.e., the more stable the micelle, the lower
the sub-micellar aggregate concentration).
35 We show
here that the higher the sub-micellar concentration, the
greater the penetration enhancement.
The strong correlation between sub-micellar sur-
factant population and barrier perturbation reported
here suggests that such population is responsible for
the eﬀect, although this cannot be conclusively proved.
Addition of C12TAB to SDS produces signiﬁcant
changes to the properties of surfactant mixtures, in
addition to reducing sub-micellar population. Notably,
addition of C12TAB increases micellar stability. Spe-
ciﬁcally, the lifetime of SDS micelles (~8 ms) is dra-
matically increased to about 2000 ms depending on the
amount of added C12TAB.
36 Addition of C12TAB also
leads to tighter packing of surfactants compared to the
loosely packed structure of SDS micelles owing to
electrostatic interactions between oppositely charged
head groups. The tight packing of surfactants could, in
principle, reduce the penetration of micelles into the
skin. Rigidity of lipid carriers has already been sug-
gested to play a major role in skin penetration. In
particular, ﬂexible, elastic vesicles have been suggested
to exhibit better penetration into skin compared to
their rigid analogs.
14,15
CONCLUSIONS
The results reported here indicate that the concen-
tration of monomers and sub-micellar aggregates cor-
relates with surfactant-mediated barrier perturbation,
whereas there is no correlation to the total surfactant
concentration. This strongly suggests that these species
(monomers/sub-micellar aggregates) are responsible
for perturbation of the skin barrier, although further
experiments are necessary to reach a ﬁrm conclusion.
Future studies should also focus on extending these
ﬁndings to additional surfactants to assess the gener-
ality of these ﬁndings.
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